Review Article
Spinal Fusion in the Next Generation: Gene and Cell Therapy Approaches
Table 2
Cell-based gene therapy in animal models of spine fusion.
| Fusion site | Specie | Cell treatment | Scaffold | Reference |
| BM-MSC | PF | Rat | None | Matrigel | [58] | PLF | Macaque | None | b-TCP | [59] | PLF | Goat | None | Ceramics | [60] | PLF | Rabbit | None | CRM | [61] | PLF | Mouse | None | Collagen | [62] | PLF | Rabbit | None | ProOsteon 500 R | [51] | PLF | Rat | None | Ceramic | [63] | PLF | Rabbit | None | HA/Collagen | [52] | AIBF | Pig | None | mPCL/TCP | [53] | PLF | Rat | Oxysterols | Collagen | [74] | PLF | Rabbit | None | TCP w/wo LIPUS | [75] | PF | Human | None | b-TCP | [76] | PLF | Rabbit | Hyperbaric O2 | Alginate | [77] | PLF | Rabbit | AdBMP2 | Collagen | [78] | PLF | Rabbit | AdBMP2 | None | [79] | PF | Rat | AdBMP7 | None | [80] | PLF | Rat | LentiBMP2 AdBMP2 | Collagen | [81] | PLF | Rat | LentiBMP2 | Collagen | [54] | PLF | Rabbit | rhBMP2 | Alginate | [82] | PLF | Rabbit | AdSmad-1c | Gelatin | [83] |
| ASC | PLF | Rat | None | TCP-Collagen | [53] | PLF | Rat | None | b-TCP-Collagen | [66] | PF | Goat | None | PLCL | [55] | PLF | Rabbit | None | nHAC-PLA | [84] | ACIF | Sheep | None | b-TCP | [85] | MLF | Pig | None | PEEK | [86] | PLF | Rat | rhBMP2 | Collagen | [87] | PF | Mice | rhBMP6 | None | [88] | PLF | Rat | AdBMP2 | Collagen | [56] | VCF | Rat | rhBMP6 | Fibrin | [89] |
|
|
PF: posterior fusion; PLF: posterolateral fusion; AIBF: anterior interbody fusion; AICF: anterior interbody cervical fusion; MLF: multi-level fusion; VCF: vertebral cervical fusion; TCP: tricalcium phosphate; CRM: compression-resistant matrix; HA/Collagen: hydroxyapatite/type 1 collagen; mPCL: medical grade poly (-caprolactone); LIPUS low-intensity pulsed ultrasound, -TCP: beta-tricalcium phosphate; PLCL: poly (L-lactide-co-caprolactone); nHAC-PLA: nanohydroxyapatite-collagen/polylactic acid; PEEK: polyetheretherketone.
|